REGENERON PHARMACEUTICALS INC
10-Q, EX-27, 2000-08-11
PHARMACEUTICAL PREPARATIONS
Previous: REGENERON PHARMACEUTICALS INC, 10-Q, 2000-08-11
Next: INVESCO FUNDS GROUP INC, 13F-HR, 2000-08-11



<TABLE> <S> <C>


<ARTICLE>                     5
<MULTIPLIER>                                      1000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                          81,751
<SECURITIES>                                    63,168
<RECEIVABLES>                                    9,568
<ALLOWANCES>                                         0
<INVENTORY>                                      7,931
<CURRENT-ASSETS>                               137,464
<PP&E>                                          70,549
<DEPRECIATION>                                  33,115
<TOTAL-ASSETS>                                 202,117
<CURRENT-LIABILITIES>                           13,027
<BONDS>                                              0
                                0
                                          0
<COMMON>                                            32
<OTHER-SE>                                     175,939
<TOTAL-LIABILITY-AND-EQUITY>                   202,117
<SALES>                                              0
<TOTAL-REVENUES>                                28,391
<CGS>                                                0
<TOTAL-COSTS>                                   38,489
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 167
<INCOME-PRETAX>                                (10,265)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (10,265)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (10,265)
<EPS-BASIC>                                      (0.31)
<EPS-DILUTED>                                    (0.31)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission